CNS Pharmaceuticals Price Chart
CNS Pharmaceuticals Volume Chart
CNS Pharmaceuticals Market Segments
Regular Trading Hours
+0.06(+2.64%)
| Open | $2.27 |
|---|---|
| Close | $2.33 |
| Low | $2.27 |
| Low Change | 0.00 (0.00%) |
| High | $2.33 |
| High Change | +0.06 (+2.64%) |
| Range | $0.06 |
| Volume | 5.955K |
| Dollar Volume | $13.88K |
Premarket
+0.17(+7.56%)
| Open | $2.24 |
|---|---|
| Close | $2.41 |
| Low | $2.24 |
| Low Change | 0.00 (0.00%) |
| High | $2.41 |
| High Change | +0.17 (+7.56%) |
| Range | $0.17 |
| Volume | 2.512K |
| Dollar Volume | $6.05K |
After Hours Yesterday
+0.00(+0.00%)
| Open | $2.27 |
|---|---|
| Close | $2.27 |
| Low | $2.27 |
| Low Change | 0.00 (0.00%) |
| High | $2.27 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 760 |
| Dollar Volume | $1.73K |
Regular Trading Hours Yesterday
+0.04(+1.79%)
| Open | $2.23 |
|---|---|
| Close | $2.27 |
| Low | $2.22 |
| Low Change | -0.01 (-0.45%) |
| High | $2.31 |
| High Change | +0.08 (+3.36%) |
| Range | $0.09 |
| Volume | 6.679K |
| Dollar Volume | $15.16K |
Premarket Yesterday
*No Trades in Segment
CNS Pharmaceuticals Moving Averages
| 5 Day Moving Average (SMA5) | $2.29 |
|---|---|
| 10 Day Moving Average (SMA10) | $2.40 |
| 20 Day Moving Average (SMA20) | $2.39 |
| 50 Day Moving Average (SMA50) | $2.61 |
| 100 Day Moving Average (SMA100) | $4.24 |
| 200 Day Moving Average (SMA200) | $5.97 |
CNS Pharmaceuticals Statistics
| Average Volume (30 Days) | 33.39K |
|---|---|
| P/E Ratio (Current) | -.12 |
| EPS (Current) | -$19.53 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$13.83M |
| Cash Ratio | 1.76 |
| Current Ratio | 1.98 |
| Quick Ratio | 1.98 |
| Debt to Equity | 0.07 |
| Enterprise Value | -$5.04M |
| EV to EBITDA | 0.32 |
| EV to Sales | — |
| Price to Book | 0.41 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -1.84% |
| Return on Equity | -3.50% |
CNS Pharmaceuticals Stock Splits
There have been 4 stock splits for CNS Pharmaceuticals (CNSP). The last reverse stock split occured on July 22, 2025 and reduced the outstanding shares at a ratio of 12:1.
| Date | Type | Ratio |
|---|---|---|
| Jul 22, 2025 | Reverse | 12:1 |
| Feb 21, 2025 | Reverse | 50:1 |
| Jun 5, 2024 | Reverse | 50:1 |
| Nov 29, 2022 | Reverse | 30:1 |
CNS Pharmaceuticals Dividends
There have been no dividends for CNS Pharmaceuticals (CNSP).